News | April 22, 2013

Zoll, Reflectance Medical Partner to Incorporate Mobile CareGuide Sensor Into Zoll Monitor/Defibrillators

New noninvasive sensor technology detects patients at onset of shock

April 22, 2013 —  Zoll Medical Corp. has entered into an agreement with Reflectance Medical Inc. to develop and market a ruggedized version of the Mobile CareGuide sensor for detecting the onset of shock in patients during air and ground military and EMS patient transports, as well as hospitalizations.

Reflectance Medical’s CareGuide sensor continuously and noninvasively monitors tissue metabolism and can be used to determine when a patient has undetected internal bleeding and may be in danger of going into shock.

Rapid treatment of traumatic injuries and shock has been shown to help save lives and reduce complications. By incorporating these new clinical parameters, Zoll’s patient monitor/defibrillators will provide more than just standard vital signs monitoring. Having early indicators of blood volume loss and impending circulatory failure in the Zoll monitor/defibrillators will ensure rapid treatment is given to the patients who need it the most.

The technology measures muscle oxygen saturation (SmO2) to determine the adequacy of tissue perfusion. Mobile CareGuide can also measure muscle pH, an indication of acidosis as well as blood hematocrit, another key parameter to assess patient status.

The goal of resuscitation from shock is to reverse acidosis and restore adequate blood flow and oxygen to all organs. Mobile CareGuide uses near-infrared light and patented algorithms to noninvasively analyze and report the blood chemistry of muscle tissue, which is the last organ to recover from traumatic injury and shock.

For more information: www.reflectancemedical.com, www.zoll.com

Related Content

wearable defibrillators prevent sudden cardiac death in pediatric patients
Feature | Sudden Cardiac Arrest| May 11, 2017
May 11, 2017 — A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in
Physio-Control Launches HeartSine samaritan PAD 360P Automated External Defibrillator in United States
Technology | Defibrillator Monitors| April 24, 2017
Physio-Control announced April 19 that the company’s HeartSine samaritan PAD 360P (SAM 360P) fully automatic external...
AEDs, automated external defibrillators, requirements, U.S. schools, JACC study
News | Defibrillator Monitors| March 30, 2017
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed...
Philips, FDA, class I recall, HeartStart MRx Monitor/Defibrillator
News | Defibrillator Monitors| March 28, 2017
Philips and the U.S. Food and Drug Administration (FDA) announced the company has initiated a recall of its HeartStart...
Zoll, Hospital Wearable Defibrillator, HWD, FDA premarket approval
Technology | Defibrillator Monitors| March 10, 2017
Zoll Medical Corp. announced that the company’s Hospital Wearable Defibrillator (HWD) has been granted premarket...
LifePak, AED, sudden cardiac arrest, defibrillator, automatic external defibrillator

A Physio-Control LifePak CR Plus defibrillator shown in use during a hand-off to paramedics, who use larger, more sophisticated defibrillator-monitors (behind gloved paramedic).

Feature | Sudden Cardiac Arrest| September 28, 2016 | Allied Market Research
Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock throug
sudden cardiac arrest, out-of-hospital, comatose patients, University of Arizona study, wake up
News | Sudden Cardiac Arrest| July 13, 2016
Physicians may be drawing conclusions too soon about survival outcomes of patients who suffered a cardiac arrest...
Zoll LifeVest wearable defibrillator, WEARIT-II Registry results, CardioStim EuroPace 2016
News | Defibrillator Monitors| June 21, 2016
Zoll Medical Corp. announced that patients experience a high one-year survival rate following use of the LifeVest...
ResQCPR System, resuscitation devices, cardiac arrest, CPR, FDA
Technology | March 09, 2015
The U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders...
Overlay Init